Patents
Patents for C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
04/2009
04/01/2009EP2041109A2 Oxathiane derivative as perfuming ingredient
04/01/2009CN101397290A Technology for preparing semi-xylenol orange by one-step method
03/2009
03/26/2009WO2009014267A3 Imidate compound and use thereof for pest control
03/24/2009US7507700 Cleaning compounds; washing, rinsing fabrics, surfaces; reacting halohydrin with a substituted or unsubstituted 3,4-dihydroisoquinoline to form an alcohol salt; sulfating to produce iminium containing compound
03/18/2009EP2036899A1 Method for producing cyclic disulfonic acid ester
03/18/2009CN101386616A 1,4-thioxane sulfinylimines compounds and preparation method thereof
03/12/2009WO2008149244A3 Compositions and methods comprising analogues of radicicol a
03/11/2009CN100467440C Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/04/2009EP1472209B1 Lipoxin a4 analogs
02/2009
02/25/2009EP1521752B1 Macrocycles for the treatment of cancer
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/19/2009US20090048190 Antiviral activity and resolution of 2-hydroxymethyl-5(5-fluorocytosin-1-yl)-1,3-oxathiolane
02/12/2009US20090043108 reacting dicholoro-o-xylene with Sodium hydroxymethanesulfinate in dimethylsulfoxide solvent in presence of NaI and K2CO3 base to form sultine, reacting sultine with maleic anhydride to form tetrahydronaphthalic anhydride as a Diels-Alder adduct, aprecursor for naphthalocyanine via benzisoindolenine
02/12/2009US20090041945 Active ray curable composition, polymerization method, active ray curable ink, image forming method, and ink-jet recording apparatus
02/03/2009US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
01/2009
01/28/2009EP2018367A1 Novel microbiocides
01/22/2009US20090023829 Multifunctional cationic photoinitiators, their preparation and use
01/21/2009EP2017274A1 Acid-amplifier having acetal group and photoresist composition including the same
01/07/2009EP2011791A1 Process for production of methylene disulfonate compound
01/07/2009EP2010512A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/07/2009CN100448876C Heterocyclocarboxamide derivatives
12/2008
12/24/2008EP2004622A1 Chiral binaphthyl sulfates for use as liquid crystal materials
12/23/2008US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
12/11/2008US20080306230 Composition and Associated Method
12/03/2008EP1997800A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
11/2008
11/27/2008WO2008141485A1 A process for stereoselective synthesis of lamivudine
11/27/2008WO2008068403A3 Method for the synthesis of n- [3- [ (2-methoxyphényl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine<0}
11/27/2008CA2688142A1 A process for stereoselective synthesis of lamivudine
11/12/2008CN100432838C Photoresist polymer and photoresist composition containing the same
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
10/2008
10/29/2008CN101293887A Purification process for high purity ring sulfate
10/29/2008CN100429197C Compound of di-butanedione, complexes of europium, combination of containing the complexes and application
10/09/2008WO2007120575A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/07/2008US7432381 1,3-oxathiolane-2-thione compounds
09/2008
09/30/2008US7429615 Cyclohexyl prostaglandin analogs as EP4-receptor agonists
09/25/2008US20080234499 Synthesising Method and Benzoxathiepine Intermediates
09/17/2008CN100418952C Biphenyl derivatives and their use as fungicides
09/16/2008US7425722 Anthra[1,9-cd:5,10-c'd']di(1,2-dithiole) derivatives; pi -electron conjugated molecules are two-dimensionally or three-dimensionally linked together
08/2008
08/28/2008WO2008101976A1 Fungicide n-(3-phenylpropyl)carboxamide derivatives
08/28/2008DE10333368B4 Oberflächenfunktionalisiertes Trägermaterial, Verfahren zu dessen Herstellung und dessen Verwendungen Surface-functionalised carrier material, process for its preparation and its uses
08/27/2008EP1960379A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
08/21/2008WO2008098375A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
08/21/2008US20080200551 Flourene Derivative
08/20/2008EP1956909A1 Microbiocides
08/20/2008EP1735324B1 Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
08/14/2008WO2008004145A3 Oxathiane derivative as perfuming ingredient
08/13/2008EP1954674A1 New n-phenethylcarboxamide derivatives
08/05/2008CA2331593C Metabolites of ecteinascidin 743
07/2008
07/31/2008WO2008091337A1 Polymer-linked-bisphosphonate inhalant formulations and methods for using the same
07/31/2008CA2669406A1 Polymer-linked-bisphosphonate inhalant formulations and methods for using the same
07/29/2008CA2348742C Carbocyclic potassium channel inhibitors
07/22/2008US7402588 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
07/16/2008EP1944301A1 Novel benzoxathiin derivative
07/10/2008WO2008082017A1 Cyclic sulfonium salt, method for production of cyclic sulfonium salt, and glycosidase inhibitor
07/08/2008US7396943 Opioid receptor antagonists
07/02/2008CN101210008A Method for preparing ethylene sulfite
07/02/2008CN101210007A Method for preparing ethylene sulfite
06/2008
06/25/2008EP1935879A1 Substituted cycloalkene derivative
06/25/2008CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph
06/24/2008US7390931 epimerizing monophospholanes and bisphospholanes by oxygen-free heating at a temperature greater or equal to 100 degree and less than or about equal to decomposition temperature of mono ro bisphospholanes; can be used as catalyst in asymmetric synthesis of valuable drugs including pregabalin.
06/19/2008WO2008052078A3 Benzoxathiine and benzoxathiole derivatives and uses thereof
06/19/2008US20080146821 Internal 1,15-Lactones Of Fluprostenol And Related Prostaglandin F2a Analogs And Their Use In The Treatment Of Glaucoma And Intraocular Hypertension
06/12/2008WO2008068403A2 Method for the synthesis of n- [3- [ (2-methoxyphényl) sulfanyl] -2- methylpropyl] -3,4-dihydro-2h-1,5-benzoxathiepin-3-amine<0}
06/10/2008US7385221 silylethynylated heteroacenes and electronic devices made with those compounds are disclosed.
06/04/2008EP0931071B1 Methods of making hiv-protease inhibitors and intermediates for making them
06/04/2008CN100391947C Biphenylcarboxamide compound
05/2008
05/29/2008US20080125586 probes, modulators or detectors of the activity of cytochrome P450 monooxygenase enzyme system, used for high throughput drug screenning
05/22/2008WO2008061029A1 Aryl sulfonamide derivatives and methods of their use
05/14/2008EP1575922B1 Biphenyl derivatives and their use as fungicides
05/07/2008EP1918287A2 LPA receptor agonists and antagonists and methods of use
05/06/2008US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
05/02/2008WO2008052078A2 Benzoxathiine and benzoxathiole derivatives and uses thereof
04/2008
04/24/2008US20080096917 for plants; 2-(dibenzofuranyl-2-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(indanyl-5-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(3-phenylquinolinyl-6-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; phytopathogenic fungi
04/23/2008EP1914225A1 Salt molten at room temperature and display device
04/23/2008EP0984928B1 Heterocyclic nitrato derivatives
04/17/2008US20080090154 electrolyte capable of improving battery characteristics even at high temperatures, a battery including the electrolyte, and a method for manufacturing an electrolyte are provided. The electrolyte contains at least one type of compound represented by the following formula:** Image-1
04/15/2008US7358275 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; The hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts
04/10/2008US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
04/09/2008CN101157681A Method for preparing 1,3 propane sultone
04/03/2008US20080081917 Poly(phenoxyalkanoic acid esters) of polyols in which the phenyl rings are substituted with sulfonium salts of thioxanthenes or thioxanthones; for use in surface coating applications, such as printing inks and varnishes
04/03/2008US20080081914 Claimed lithium or amine salt; for zonisamide production
04/02/2008CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient
04/01/2008US7351727 Inhibitors of 15-lipoxygenase
04/01/2008US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient
03/2008
03/27/2008WO2008035737A1 4-nitrobenzoyl derivative having sulfoxyimino group and herbicide for rice plant
03/20/2008WO2008032463A1 Process for production of sulfonic acid ester
03/20/2008US20080070978 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure
03/19/2008CN101146777A Carboxanilides as microbiocides
03/06/2008US20080058389 Carboxamides
03/04/2008US7338742 Photoresist polymer and photoresist composition containing the same
02/2008
02/28/2008US20080051446 Heterocyclocarboxamide Derivatives
02/27/2008EP1891005A2 Process for preparation of 13,14-dihydro-pgf2 alpha derivatives
02/19/2008CA2183714C Synthesis of 1,3-oxathiolane sulfoxide compounds
02/07/2008US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
02/05/2008US7326695 Anti-bacterial agents based upon oxoanion binding
01/2008
01/17/2008WO2008008273A1 Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide
01/17/2008CA2656767A1 Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide
12/2007
12/27/2007WO2007148597A1 Method for producing cyclic disulfonic acid ester
12/27/2007US20070299051 Tricyclic Guanidine Derivatives as Sodium-Proton Exchange Inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 25